Three well-characterized human colorectal carcinoma cell lines (HCT-116, HCT-116 (p53−/−) and HT-29) were chosen to study the ability of p21-sa-RNA-332 to activate p21 expression. This evidence concerns the gene TP53 and colorectal carcinoma.